Sign In

Pek Lum

Bringing precise medicines to patients

Pek Lum is the CEO and Founder of Auransa Inc., an AI-driven pharmaceutical startup dedicated to developing precise medications for cancer, aging-related conditions, and other disorders.

With a Ph.D. from the University of Washington, a Master of Science (M.Sc.) and Bachelor of Science (B.Sc.) from Hokkaido University, and Nihongo Gakko studies from Tokyo University of Foreign Studies, Pek Lum boasts a diverse educational background.

Prior to founding Auransa Inc., Pek Lum held advisory roles at various organizations including Sequence Bio, The Michael J. Fox Foundation for Parkinson's Research, Bayes Impact, U-BIOPRED, Clearfork Bioscience, and served in leadership positions at Ayasdi, iPierian, and Rosetta/Merck.

Pek Lum and the team at Auransa Inc. comprise seasoned professionals from drug development, data science, biology, and chemistry fields with a collective objective of creating treatments to combat severe human illnesses and alleviate suffering.

Highlights

Israeli CEO seeks quantum of solace for women’s diseases - The Times of Israel
Jun 4 · PRNewswire
Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases - PRNewswire
Pek Lum
Add to my network

Location

San Francisco Bay Area